Single User License
INR 96975
Site License
INR 193950
Corporate User License
INR 290925

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Circassia Pharmaceuticals Plc-Product Pipeline Review-2015

Circassia Pharmaceuticals Plc-Product Pipeline Review-2015

  • Products Id :- GMDHC07433CDB
  • |
  • Pages: 36
  • |
  • August 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Circassia Pharmaceuticals Plc-Product Pipeline Review-2015


Global Markets Direct's, 'Circassia Pharmaceuticals plc-Product Pipeline Review-2015', provides an overview of the Circassia Pharmaceuticals plc's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Circassia Pharmaceuticals plc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Circassia Pharmaceuticals plc including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Circassia Pharmaceuticals plc's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Circassia Pharmaceuticals plc's pipeline products

Reasons To Buy

Evaluate Circassia Pharmaceuticals plc's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Circassia Pharmaceuticals plc in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Circassia Pharmaceuticals plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Circassia Pharmaceuticals plc and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Circassia Pharmaceuticals plc

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Circassia Pharmaceuticals plc and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Circassia Pharmaceuticals Plc Snapshot 5

Circassia Pharmaceuticals Plc Overview 5

Key Information 5

Key Facts 5

Circassia Pharmaceuticals Plc-Research and Development Overview 6

Key Therapeutic Areas 6

Circassia Pharmaceuticals Plc-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Circassia Pharmaceuticals Plc-Pipeline Products Glance 11

Circassia Pharmaceuticals Plc-Late Stage Pipeline Products 11

Phase III Products/Combination Treatment Modalities 11

Circassia Pharmaceuticals Plc-Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Circassia Pharmaceuticals Plc-Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Circassia Pharmaceuticals Plc-Drug Profiles 14

Vaccine for Cat Allergy 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Birch-SPIRE 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Vaccine for Allergic Rhino-Conjunctivitis and House Dust Mite Allergy 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Vaccine for Asthma, Grass Pollen Allergy and Allergic Rhino-Conjunctivitis 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Vaccine for Asthma, Ragweed Allergy and Rhino-Conjunctivitis 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Vaccine for Alternaria Allergy 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Vaccine for Cedar Pollen Allergy 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Circassia Pharmaceuticals Plc-Pipeline Analysis 26

Circassia Pharmaceuticals Plc-Pipeline Products by Target 26

Circassia Pharmaceuticals Plc-Pipeline Products by Route of Administration 27

Circassia Pharmaceuticals Plc-Pipeline Products by Molecule Type 28

Circassia Pharmaceuticals Plc-Recent Pipeline Updates 29

Circassia Pharmaceuticals Plc-Dormant Projects 33

Circassia Pharmaceuticals Plc-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Appendix 35

Methodology 35

Coverage 35

Secondary Research 35

Primary Research 35

Expert Panel Validation 35

Contact Us 35

Disclaimer 36

List of Tables

Circassia Pharmaceuticals Plc, Key Information 5

Circassia Pharmaceuticals Plc, Key Facts 5

Circassia Pharmaceuticals Plc-Pipeline by Indication, 2015 8

Circassia Pharmaceuticals Plc-Pipeline by Stage of Development, 2015 9

Circassia Pharmaceuticals Plc-Monotherapy Products in Pipeline, 2015 10

Circassia Pharmaceuticals Plc-Phase III, 2015 11

Circassia Pharmaceuticals Plc-Phase II, 2015 12

Circassia Pharmaceuticals Plc-Preclinical, 2015 13

Circassia Pharmaceuticals Plc-Pipeline by Target, 2015 26

Circassia Pharmaceuticals Plc-Pipeline by Route of Administration, 2015 27

Circassia Pharmaceuticals Plc-Pipeline by Molecule Type, 2015 28

Circassia Pharmaceuticals Plc-Recent Pipeline Updates, 2015 29

Circassia Pharmaceuticals Plc-Dormant Developmental Projects,2015 33

Circassia Pharmaceuticals Plc, Subsidiaries 34

List of Figures

Circassia Pharmaceuticals Plc-Pipeline by Top 10 Indication, 2015 7

Circassia Pharmaceuticals Plc-Pipeline by Stage of Development, 2015 9

Circassia Pharmaceuticals Plc-Monotherapy Products in Pipeline, 2015 10

Circassia Pharmaceuticals Plc-Pipeline by Top 10 Target, 2015 26

Circassia Pharmaceuticals Plc-Pipeline by Top 10 Route of Administration, 2015 27

Circassia Pharmaceuticals Plc-Pipeline by Top 10 Molecule Type, 2015 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Circassia Pharmaceuticals plc; Circassia Pharmaceuticals plc - Key Therapeutics; Circassia Pharmaceuticals plc - Pipeline Overview and Promising Molecules; Circassia Pharmaceuticals plc - News; Circassia Pharmaceuticals plc - Latest Updates; Circassia Pharmaceuticals plc - Pipeline; Circassia Pharmaceuticals plc - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]